Mineralys Therapeutics CMO David Rodman sells $58,785 in stock — See source for full details.
$MLYS
Price history, market instrument context, member research, and related headlines in one place.
MLYS key statistics
NasdaqGSUSD
52-week range
$20.415%$47.65
Latest session $20.83–$21.83Mineralys Therapeutics, Inc. (MLYS) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $21.64, up $0.88 (4.24%) from the previous close of $20.76. It has traded between $20.83 and $21.83 in the latest session. Over the past year it has ranged from $20.41 to $47.65, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Mineralys outlines launch readiness ahead of December 22, 2026 PDUFA, with cash runway into 2028 — See source for full details.
Loading $MLYS research…